This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 58791 |
covid-19 | patients | 16444 |
novel | coronavirus | 15286 |
covid-19 | pandemic | 8757 |
public | health | 8687 |
covid-19 | infection | 8373 |
covid-19 | cases | 6402 |
- | analysis | 5533 |
immune | response | 3627 |
- | risk | 3368 |
- | time | 3202 |
- | level | 2797 |
severe | disease | 2640 |
high | risk | 2561 |
higher | risk | 2461 |
- | cell | 2205 |
severe | cases | 2171 |
viral | infection | 2161 |
viral | infections | 2079 |
- | care | 2072 |
respiratory | symptoms | 1930 |
immune | responses | 1767 |
severe | covid-19 | 1726 |
new | coronavirus | 1581 |
first | case | 1386 |
new | cases | 1305 |
severe | patients | 1216 |
respiratory | disease | 1214 |
high | levels | 1194 |
immune | cells | 1087 |
large | number | 1086 |
clinical | symptoms | 1080 |
higher | levels | 1048 |
positive | patients | 1044 |
clinical | data | 996 |
- | infection | 983 |
covid-19 | disease | 975 |
clinical | studies | 943 |
other | studies | 941 |
covid-19 | infections | 926 |
- | sars | 924 |
human | coronavirus | 922 |
respiratory | infections | 905 |
respiratory | infection | 902 |
positive | cases | 896 |
medical | care | 894 |
covid-19 | symptoms | 887 |
covid-19 | patient | 865 |
available | data | 806 |
- | pandemic | 788 |
- | coronavirus | 735 |
many | patients | 675 |
severe | coronavirus | 674 |
high | level | 653 |
respiratory | viruses | 649 |
respiratory | diseases | 628 |
- | analyses | 619 |
- | day | 606 |
severe | symptoms | 600 |
- | cells | 584 |
low | risk | 563 |
other | patients | 561 |
potential | risk | 536 |
- | patient | 480 |
- | case | 450 |
severe | sars | 440 |
first | time | 439 |
lower | risk | 422 |
positive | results | 417 |
highest | number | 409 |
severe | infection | 403 |
acute | care | 399 |
clinical | care | 385 |
first | study | 382 |
respiratory | virus | 368 |
low | levels | 366 |
first | cases | 365 |
- | health | 354 |
immune | cell | 352 |
lower | levels | 351 |
higher | level | 347 |
many | cases | 343 |
other | symptoms | 339 |
high | number | 337 |
other | diseases | 333 |
such | patients | 333 |
highest | risk | 330 |
covid-19 | risk | 327 |
first | covid-19 | 321 |
novel | virus | 321 |
covid-19 | treatment | 316 |
positive | sars | 314 |
human | health | 309 |
medical | treatment | 297 |
- | response | 296 |
many | studies | 296 |
other | health | 293 |
clinical | study | 291 |
more | time | 287 |
other | viruses | 287 |
positive | result | 286 |
first | day | 284 |
potential | treatment | 284 |
new | virus | 281 |
- | china | 279 |
viral | diseases | 278 |
different | levels | 272 |
significant | risk | 260 |
- | covid-19 | 257 |
new | disease | 255 |
large | numbers | 245 |
- | treatment | 243 |
- | virus | 240 |
more | data | 235 |
human | cells | 234 |
higher | number | 232 |
new | infections | 228 |
viral | disease | 215 |
more | patients | 214 |
covid-19 | response | 206 |
potential | risks | 203 |
different | time | 200 |
- | infections | 193 |
low | level | 191 |
significant | number | 189 |
- | days | 189 |
early | days | 186 |
more | cases | 185 |
such | cases | 183 |
early | treatment | 179 |
first | patient | 179 |
covid-19 | case | 177 |
low | number | 175 |
positive | covid-19 | 172 |
medical | patients | 171 |
other | coronavirus | 170 |
highest | level | 169 |
severe | infections | 168 |
new | data | 167 |
- | study | 165 |
important | risk | 164 |
positive | patient | 164 |
new | patients | 162 |
new | covid-19 | 158 |
novel | sars | 154 |
different | studies | 150 |
more | studies | 146 |
lower | level | 143 |
clinical | treatment | 139 |
acute | infection | 138 |
human | infection | 134 |
other | risk | 134 |
largest | number | 133 |
other | infections | 131 |
- | patients | 130 |
clinical | case | 129 |
social | care | 129 |
human | studies | 126 |
other | cases | 126 |
severe | case | 125 |
early | data | 124 |
covid-19 | virus | 121 |
first | symptoms | 121 |
human | cell | 121 |
- | disease | 119 |
such | data | 117 |
other | treatments | 116 |
larger | studies | 115 |
novel | disease | 115 |
higher | case | 113 |
early | studies | 112 |
clinical | disease | 111 |
such | studies | 108 |
covid-19 | treatments | 108 |
potential | treatments | 107 |
larger | number | 106 |
positive | case | 106 |
clinical | analysis | 103 |
covid-19 | coronavirus | 102 |
new | infection | 102 |
clinical | risk | 98 |
covid-19 | symptom | 98 |
human | cases | 98 |
many | health | 97 |
respiratory | coronavirus | 97 |
different | times | 96 |
first | days | 96 |
first | symptom | 95 |
higher | risks | 93 |
other | covid-19 | 93 |
clinical | cases | 93 |
such | models | 92 |
clinical | response | 92 |
high | case | 92 |
high | infection | 90 |
other | disease | 87 |
different | cell | 83 |
different | models | 83 |
more | days | 83 |
potential | covid-19 | 82 |
earlier | studies | 81 |
- | model | 81 |
acute | covid-19 | 80 |
other | cells | 80 |
other | data | 80 |
human | disease | 79 |
lower | number | 79 |
severe | pandemic | 79 |
viral | pandemic | 79 |
severe | diseases | 78 |
other | models | 78 |
human | sars | 77 |
medical | health | 76 |
highest | levels | 74 |
new | pandemic | 74 |
early | covid-19 | 73 |
new | treatment | 73 |
other | patient | 73 |
early | disease | 72 |
higher | infection | 71 |
high | numbers | 71 |
different | disease | 68 |
other | study | 68 |
available | studies | 67 |
early | infection | 67 |
novel | covid-19 | 67 |
lower | case | 66 |
large | study | 65 |
more | symptoms | 65 |
different | patients | 65 |
larger | study | 63 |
human | diseases | 63 |
early | cases | 62 |
early | symptoms | 62 |
other | pandemics | 62 |
acute | sars | 61 |
different | patient | 60 |
early | response | 60 |
acute | infections | 60 |
different | health | 59 |
different | risk | 58 |
many | times | 58 |
- | cases | 57 |
medical | data | 57 |
significant | results | 57 |
new | symptoms | 56 |
potential | infection | 56 |
medical | treatments | 56 |
low | numbers | 56 |
largest | study | 55 |
other | treatment | 55 |
covid-19 | pandemics | 54 |
higher | numbers | 54 |
many | viruses | 54 |
public | response | 54 |
covid-19 | risks | 52 |
more | risk | 52 |
new | patient | 51 |
positive | cells | 51 |
potential | health | 51 |
new | case | 50 |
viral | response | 50 |
severe | health | 50 |
potential | sars | 50 |
severe | patient | 50 |
low | health | 50 |
first | model | 50 |
clinical | results | 50 |
first | studies | 50 |
different | treatment | 49 |
different | viruses | 49 |
first | sars | 49 |
viral | pandemics | 49 |
respiratory | treatments | 48 |
new | model | 48 |
acute | disease | 48 |
first | results | 47 |
new | studies | 47 |
respiratory | care | 47 |
different | diseases | 46 |
other | sars | 46 |
higher | covid-19 | 45 |
human | infections | 45 |
such | symptoms | 45 |
first | coronavirus | 45 |
early | case | 45 |
covid-19 | health | 44 |
new | models | 44 |
new | sars | 44 |
new | treatments | 44 |
respiratory | symptom | 44 |
novel | treatment | 43 |
novel | viruses | 43 |
different | results | 43 |
clinical | symptom | 43 |
- | data | 42 |
different | data | 42 |
large | case | 42 |
many | days | 42 |
potential | cases | 42 |
potential | patients | 42 |
available | case | 41 |
first | infection | 41 |
viral | cell | 41 |
significant | health | 40 |
high | disease | 40 |
different | study | 40 |
other | case | 39 |
covid-19 | diseases | 38 |
high | covid-19 | 38 |
public | responses | 38 |
non | covid-19 | 38 |
covid-19 | results | 38 |
first | pandemic | 38 |
earlier | study | 38 |
covid-19 | care | 37 |
many | diseases | 37 |
acute | patients | 36 |
early | study | 36 |
large | studies | 36 |
low | case | 36 |
public | data | 36 |
early | symptom | 35 |
other | virus | 35 |
large | health | 35 |
such | pandemics | 35 |
different | symptoms | 35 |
- | times | 35 |
other | infection | 35 |
acute | treatment | 35 |
significant | levels | 34 |
such | results | 34 |
covid-19 | model | 34 |
- | models | 33 |
lowest | level | 33 |
respiratory | sars | 32 |
significant | time | 32 |
significant | symptoms | 32 |
significant | level | 32 |
lowest | risk | 32 |
novel | case | 32 |
new | diseases | 32 |
different | covid-19 | 32 |
different | treatments | 32 |
new | viruses | 31 |
other | pandemic | 31 |
high | sars | 31 |
highest | case | 31 |
- | studied | 31 |
available | covid-19 | 30 |
covid-19 | responses | 30 |
different | responses | 30 |
early | results | 30 |
other | time | 30 |
significant | risks | 30 |
covid-19 | data | 30 |
respiratory | health | 29 |
viral | treatment | 29 |
such | treatment | 29 |
severe | levels | 29 |
early | sars | 29 |
new | health | 29 |
acute | symptoms | 29 |
- | levels | 29 |
low | infection | 28 |
public | risk | 28 |
more | times | 28 |
higher | disease | 28 |
larger | numbers | 28 |
highest | numbers | 28 |
covid-19 | levels | 28 |
- | symptom | 27 |
high | risks | 27 |
lower | health | 27 |
other | cell | 27 |
other | day | 27 |
positive | response | 27 |
such | risk | 27 |
lowest | number | 26 |
such | analyses | 26 |
significant | numbers | 26 |
new | study | 26 |
human | data | 26 |
first | patients | 26 |
- | studies | 26 |
available | treatment | 26 |
clinical | time | 25 |
covid-19 | studies | 25 |
social | health | 25 |
first | response | 24 |
important | data | 24 |
low | response | 24 |
medical | response | 24 |
respiratory | treatment | 24 |
such | case | 24 |
many | cells | 23 |
such | study | 23 |
such | diseases | 23 |
novel | treatments | 23 |
novel | pandemic | 23 |
clinical | model | 23 |
high | patient | 23 |
different | days | 23 |
lowest | levels | 23 |
larger | patient | 22 |
acute | health | 22 |
covid-19 | covid-19 | 22 |
early | analysis | 22 |
first | analysis | 22 |
lower | numbers | 22 |
new | symptom | 22 |
novel | infection | 22 |
such | pandemic | 22 |
more | patient | 21 |
human | patients | 21 |
such | treatments | 21 |
human | viruses | 21 |
severe | risk | 21 |
human | covid-19 | 21 |
earlier | time | 21 |
clinical | levels | 21 |
highest | infection | 21 |
new | risk | 20 |
such | times | 20 |
severe | symptom | 20 |
other | times | 20 |
other | risks | 20 |
other | analyses | 20 |
many | infections | 20 |
early | risk | 20 |
early | pandemic | 20 |
earlier | sars | 20 |
different | infection | 20 |
clinical | models | 20 |
available | health | 20 |
- | number | 20 |
lower | infection | 19 |
potential | disease | 19 |
positive | virus | 19 |
other | symptom | 19 |
more | infections | 19 |
different | cases | 19 |
lower | covid-19 | 19 |
important | health | 19 |
different | level | 19 |
acute | diseases | 19 |
clinical | covid-19 | 18 |
high | response | 18 |
largest | case | 18 |
novel | risk | 18 |
respiratory | patients | 18 |
social | responses | 18 |
social | risk | 18 |
such | time | 18 |
such | risks | 17 |
significant | disease | 17 |
respiratory | cells | 17 |
many | models | 17 |
larger | case | 17 |
different | sars | 17 |
clinical | level | 17 |
different | number | 17 |
large | patient | 16 |
- | diseases | 16 |
viral | symptoms | 16 |
other | results | 16 |
more | number | 16 |
such | cells | 16 |
human | study | 16 |
higher | health | 16 |
different | virus | 16 |
clinical | treatments | 16 |
- | symptoms | 16 |
many | risk | 15 |
viral | responses | 15 |
such | analysis | 15 |
potential | coronavirus | 15 |
positive | symptoms | 15 |
positive | health | 15 |
medical | risk | 15 |
many | symptoms | 15 |
different | numbers | 15 |
many | cell | 15 |
different | response | 15 |
different | pandemic | 15 |
different | cells | 15 |
clinical | patient | 15 |
available | treatments | 15 |
available | sars | 15 |
acute | pandemic | 15 |
potential | pandemic | 14 |
such | disease | 14 |
significant | result | 14 |
significant | infection | 14 |
positive | days | 14 |
different | case | 14 |
other | model | 14 |
first | level | 14 |
available | time | 14 |
viral | sars | 13 |
significant | data | 13 |
potential | virus | 13 |
potential | studies | 13 |
positive | responses | 13 |
positive | disease | 13 |
other | care | 13 |
low | disease | 13 |
important | symptoms | 13 |
human | response | 13 |
human | models | 13 |
higher | sars | 13 |
first | treatment | 13 |
first | data | 13 |
early | time | 13 |
different | risks | 13 |
different | model | 13 |
covid-19 | study | 13 |
acute | cases | 13 |
medical | studies | 12 |
potential | symptoms | 12 |
novel | diseases | 12 |
novel | data | 12 |
social | response | 12 |
social | risks | 12 |
such | care | 12 |
such | infections | 12 |
many | case | 12 |
many | disease | 12 |
many | levels | 12 |
larger | covid-19 | 12 |
early | infections | 12 |
early | analyses | 12 |
earliest | cases | 12 |
earlier | virus | 12 |
clinical | responses | 12 |
acute | response | 12 |
- | results | 12 |
- | caring | 12 |
high | virus | 12 |
medical | responses | 11 |
such | health | 11 |
significant | patient | 11 |
other | responses | 11 |
more | sars | 11 |
more | health | 11 |
large | data | 11 |
important | study | 11 |
high | time | 11 |
earlier | treatment | 11 |
earlier | pandemics | 11 |
covid-19 | time | 11 |
new | pandemics | 10 |
viral | cases | 10 |
such | viruses | 10 |
respiratory | covid-19 | 10 |
public | coronavirus | 10 |
potential | pandemics | 10 |
potential | case | 10 |
positive | infection | 10 |
novel | model | 10 |
potential | patient | 10 |
more | virus | 10 |
many | care | 10 |
lower | risks | 10 |
low | covid-19 | 10 |
larger | health | 10 |
highest | cases | 10 |
high | health | 10 |
different | coronavirus | 10 |
- | timed | 10 |
more | care | 10 |
new | cells | 9 |
lower | patient | 9 |
many | sars | 9 |
medical | cases | 9 |
more | coronavirus | 9 |
significant | symptom | 9 |
new | results | 9 |
novel | health | 9 |
respiratory | pandemic | 9 |
severe | pandemics | 9 |
low | patient | 9 |
such | responses | 9 |
low | risks | 9 |
important | coronavirus | 9 |
important | result | 9 |
higher | cases | 9 |
- | modeling | 9 |
covid-19 | numbers | 9 |
earlier | coronavirus | 9 |
important | patient | 9 |
early | patients | 9 |
earliest | days | 9 |
higher | response | 9 |
human | responses | 9 |
immune | disease | 9 |
immune | diseases | 9 |
immune | health | 9 |
more | symptom | 8 |
new | levels | 8 |
new | risks | 8 |
other | levels | 8 |
positive | number | 8 |
many | risks | 8 |
potential | model | 8 |
potential | number | 8 |
potential | study | 8 |
severe | level | 8 |
viral | treatments | 8 |
more | disease | 8 |
early | times | 8 |
lower | virus | 8 |
higher | patient | 8 |
- | result | 8 |
available | results | 8 |
earlier | data | 8 |
early | responses | 8 |
largest | numbers | 8 |
higher | virus | 8 |
human | virus | 8 |
important | time | 8 |
largest | health | 8 |
lower | disease | 7 |
viral | studies | 7 |
social | data | 7 |
severe | risks | 7 |
potential | infections | 7 |
positive | coronavirus | 7 |
new | care | 7 |
more | infection | 7 |
more | case | 7 |
many | treatments | 7 |
many | treatment | 7 |
many | data | 7 |
medical | model | 7 |
low | virus | 7 |
earliest | time | 7 |
largest | risk | 7 |
acute | coronavirus | 7 |
acute | responses | 7 |
covid-19 | viruses | 7 |
earlier | days | 7 |
clinical | infection | 7 |
early | care | 7 |
early | virus | 7 |
first | cell | 7 |
large | covid-19 | 7 |
more | pandemic | 6 |
largest | pandemic | 6 |
largest | studies | 6 |
lower | sars | 6 |
lowest | numbers | 6 |
many | patient | 6 |
medical | diseases | 6 |
more | cells | 6 |
more | covid-19 | 6 |
respiratory | pandemics | 6 |
more | risks | 6 |
new | level | 6 |
new | time | 6 |
positive | data | 6 |
potential | data | 6 |
such | response | 6 |
viral | models | 6 |
important | treatment | 6 |
large | infections | 6 |
significant | covid-19 | 6 |
important | results | 6 |
covid-19 | analysis | 6 |
humans | sars | 6 |
- | responses | 6 |
- | resulting | 6 |
- | et | 6 |
- | treatments | 6 |
available | patient | 6 |
clinical | analyses | 6 |
clinical | health | 6 |
acute | virus | 6 |
different | infections | 6 |
first | health | 6 |
first | virus | 6 |
higher | results | 6 |
highest | response | 6 |
highest | results | 6 |
first | disease | 6 |
human | model | 6 |
more | cell | 5 |
new | number | 5 |
more | viruses | 5 |
more | study | 5 |
many | time | 5 |
medical | patient | 5 |
medical | covid-19 | 5 |
other | days | 5 |
newer | data | 5 |
viral | risk | 5 |
other | studied | 5 |
positive | cell | 5 |
positive | numbers | 5 |
positive | treatment | 5 |
public | covid-19 | 5 |
severe | response | 5 |
social | level | 5 |
such | levels | 5 |
low | cell | 5 |
many | coronavirus | 5 |
medical | disease | 5 |
large | cell | 5 |
early | models | 5 |
important | studies | 5 |
- | viruses | 5 |
available | number | 5 |
available | patients | 5 |
covid-19 | models | 5 |
covid-19 | resulting | 5 |
different | care | 5 |
earlier | cases | 5 |
earlier | results | 5 |
clinical | sars | 5 |
early | patient | 5 |
higher | pandemic | 5 |
higher | symptoms | 5 |
highest | risks | 5 |
human | patient | 5 |
important | case | 5 |
important | disease | 5 |
first | analyses | 5 |
important | number | 5 |
more | pandemics | 4 |
other | analysis | 4 |
novel | cell | 4 |
new | cell | 4 |
new | analyses | 4 |
more | responses | 4 |
many | study | 4 |
medical | case | 4 |
many | virus | 4 |
many | model | 4 |
many | covid-19 | 4 |
other | response | 4 |
other | numbers | 4 |
social | studies | 4 |
others | studies | 4 |
positive | risk | 4 |
respiratory | responses | 4 |
severe | responses | 4 |
severe | virus | 4 |
significant | pandemic | 4 |
significant | response | 4 |
social | analysis | 4 |
social | model | 4 |
such | infection | 4 |
viral | model | 4 |
low | symptom | 4 |
lower | cases | 4 |
new | analysis | 4 |
low | sars | 4 |
earliest | studies | 4 |
low | coronavirus | 4 |
acute | treatments | 4 |
available | models | 4 |
available | study | 4 |
clinical | infections | 4 |
covid-19 | level | 4 |
covid-19 | result | 4 |
covid-19 | times | 4 |
different | analyses | 4 |
different | symptom | 4 |
earlier | times | 4 |
earliest | case | 4 |
available | symptoms | 4 |
early | coronavirus | 4 |
important | cell | 4 |
first | result | 4 |
large | treatment | 4 |
large | analysis | 4 |
important | treatments | 4 |
large | model | 4 |
highest | disease | 4 |
acute | patient | 4 |
high | cases | 4 |
high | care | 4 |
largest | patient | 4 |
positives | cases | 3 |
more | treatment | 3 |
novel | study | 3 |
novel | studies | 3 |
novel | patient | 3 |
novel | cases | 3 |
non | time | 3 |
new | responses | 3 |
new | response | 3 |
lowest | results | 3 |
more | analysis | 3 |
medical | symptoms | 3 |
medical | level | 3 |
many | responses | 3 |
lower | treatment | 3 |
lower | time | 3 |
lower | response | 3 |
lower | cell | 3 |
potential | response | 3 |
potential | diseases | 3 |
significant | sars | 3 |
potential | result | 3 |
significant | responses | 3 |
viral | case | 3 |
such | sars | 3 |
such | numbers | 3 |
such | model | 3 |
such | level | 3 |
such | covid-19 | 3 |
significant | study | 3 |
largest | analysis | 3 |
significant | model | 3 |
potential | symptom | 3 |
significant | infections | 3 |
significant | cases | 3 |
significant | case | 3 |
severest | cases | 3 |
severe | treatment | 3 |
severe | time | 3 |
public | levels | 3 |
potential | time | 3 |
low | cases | 3 |
new | day | 3 |
larger | time | 3 |
different | pandemics | 3 |
first | infections | 3 |
early | treatments | 3 |
early | result | 3 |
earliest | symptoms | 3 |
earliest | patients | 3 |
earliest | data | 3 |
earlier | analysis | 3 |
different | result | 3 |
covid-19 | days | 3 |
first | risk | 3 |
covid-19 | analyses | 3 |
clinical | diseases | 3 |
available | virus | 3 |
available | cases | 3 |
- | risks | 3 |
- | numbers | 3 |
- | numbered | 3 |
larger | response | 3 |
first | models | 3 |
different | day | 3 |
first | studied | 3 |
immune | levels | 3 |
larger | data | 3 |
high | cell | 3 |
large | virus | 3 |
large | time | 3 |
large | infection | 3 |
important | diseases | 3 |
important | cells | 3 |
immune | studies | 3 |
important | infection | 3 |
human | level | 3 |
human | case | 3 |
human | caring | 3 |
highest | result | 3 |
higher | time | 3 |
high | treatment | 3 |
immune | analysis | 3 |
high | symptom | 3 |
high | pandemic | 3 |
new | numbers | 2 |
more | diseases | 2 |
medical | cares | 2 |
medical | infections | 2 |
medical | models | 2 |
medical | risks | 2 |
more | response | 2 |
more | level | 2 |
more | numbers | 2 |
more | results | 2 |
many | analyses | 2 |
many | results | 2 |
largest | coronavirus | 2 |
lowest | health | 2 |
large | risk | 2 |
lowest | case | 2 |
lower | symptoms | 2 |
lower | symptom | 2 |
lower | results | 2 |
largest | data | 2 |
largest | covid-19 | 2 |
largest | cases | 2 |
larger | patients | 2 |
newer | infections | 2 |
new | result | 2 |
significant | treatment | 2 |
newer | studies | 2 |
respiratory | response | 2 |
viral | levels | 2 |
such | virus | 2 |
such | patient | 2 |
social | et | 2 |
significant | pandemics | 2 |
significant | cell | 2 |
significant | care | 2 |
severer | symptoms | 2 |
severer | disease | 2 |
respiratory | risk | 2 |
respiratory | patient | 2 |
non | coronavirus | 2 |
potential | responses | 2 |
positives | results | 2 |
positive | symptom | 2 |
positive | studies | 2 |
others | symptoms | 2 |
others | studied | 2 |
other | number | 2 |
novel | results | 2 |
novel | pandemics | 2 |
novel | infections | 2 |
larger | cells | 2 |
immune | treatment | 2 |
large | response | 2 |
covid-19 | china | 2 |
early | level | 2 |
earlier | symptoms | 2 |
earlier | patients | 2 |
earlier | patient | 2 |
earlier | disease | 2 |
earlier | case | 2 |
different | analysis | 2 |
covid-19 | sars | 2 |
covid-19 | number | 2 |
covid-19 | et | 2 |
clinical | day | 2 |
first | number | 2 |
available | result | 2 |
available | infection | 2 |
available | disease | 2 |
available | coronavirus | 2 |
available | care | 2 |
acute | symptom | 2 |
- | pandemics | 2 |
- | modeled | 2 |
- | al | 2 |
large | patients | 2 |
first | cells | 2 |
clinical | patients | 2 |
first | responses | 2 |
human | pandemics | 2 |
large | level | 2 |
first | resulted | 2 |
large | day | 2 |
important | symptom | 2 |
important | sars | 2 |
important | response | 2 |
important | pandemic | 2 |
important | day | 2 |
immune | study | 2 |
human | symptoms | 2 |
important | models | 2 |
higher | symptom | 2 |
human | pandemic | 2 |
highest | virus | 2 |
highest | symptom | 2 |
highest | sars | 2 |
highest | responses | 2 |
higher | treatment | 2 |
high | % | 2 |
higher | care | 2 |
high | result | 2 |
high | coronavirus | 2 |
newest | data | 1 |
mores | et | 1 |
newest | disease | 1 |
newer | viruses | 1 |
newest | health | 1 |
newest | coronavirus | 1 |
new | cov-2 | 1 |
newer | treatments | 1 |
newer | symptoms | 1 |
newer | diseases | 1 |
mores | studies | 1 |
newest | sars | 1 |
newest | pandemic | 1 |
others | coronavirus | 1 |
non | health | 1 |
non | patient | 1 |
novel | analyses | 1 |
novel | analysis | 1 |
novel | care | 1 |
novel | symptoms | 1 |
novel | times | 1 |
other | modelling | 1 |
other | result | 1 |
other | resulting | 1 |
others | days | 1 |
others | infection | 1 |
more | resulted | 1 |
more | studied | 1 |
low | symptoms | 1 |
more | model | 1 |
more | levels | 1 |
low | resulting | 1 |
low | results | 1 |
low | study | 1 |
others | models | 1 |
lower | cells | 1 |
lower | infections | 1 |
lower | model | 1 |
lower | pandemic | 1 |
lower | patients | 1 |
lowest | cases | 1 |
lowest | infection | 1 |
lowest | response | 1 |
lowest | virus | 1 |
many | day | 1 |
many | infection | 1 |
many | modeling | 1 |
many | pandemic | 1 |
many | pandemics | 1 |
medical | analyses | 1 |
medical | analysis | 1 |
medical | coronavirus | 1 |
medical | infection | 1 |
medical | study | 1 |
medical | time | 1 |
more | day | 1 |
others | modeled | 1 |
public | et | 1 |
others | patients | 1 |
significant | coronavirus | 1 |
respiratory | case | 1 |
respiratory | cases | 1 |
respiratory | cell | 1 |
respiratory | data | 1 |
respiratory | level | 1 |
respiratory | levels | 1 |
respiratory | models | 1 |
respiratory | results | 1 |
severe | data | 1 |
severe | models | 1 |
severe | studies | 1 |
severer | covid-19 | 1 |
significant | days | 1 |
public | time | 1 |
significant | studies | 1 |
significant | virus | 1 |
social | cases | 1 |
social | levels | 1 |
such | day | 1 |
such | days | 1 |
such | number | 1 |
such | result | 1 |
such | symptom | 1 |
viral | al | 1 |
viral | analysis | 1 |
viral | cells | 1 |
public | virus | 1 |
public | sars | 1 |
others | resulted | 1 |
potential | cells | 1 |
others | study | 1 |
positive | care | 1 |
positive | cov-2 | 1 |
positive | et | 1 |
positive | infections | 1 |
positive | levels | 1 |
positive | study | 1 |
positive | time | 1 |
positives | patient | 1 |
positives | patients | 1 |
potential | analysis | 1 |
potential | care | 1 |
potential | cov-2 | 1 |
public | results | 1 |
potential | level | 1 |
potential | levels | 1 |
potential | models | 1 |
potential | numbers | 1 |
potential | results | 1 |
potentials | risks | 1 |
public | care | 1 |
public | case | 1 |
low | patients | 1 |
public | level | 1 |
public | pandemic | 1 |
public | patients | 1 |
low | responses | 1 |
important | infections | 1 |
low | pandemic | 1 |
earlier | models | 1 |
covid-19 | cell | 1 |
covid-19 | cells | 1 |
covid-19 | day | 1 |
covid-19 | modelling | 1 |
covid-19 | resulted | 1 |
different | % | 1 |
different | cares | 1 |
different | studied | 1 |
earlier | analyses | 1 |
earlier | covid-19 | 1 |
earlier | diseases | 1 |
earlier | infections | 1 |
earlier | number | 1 |
early | levels | 1 |
earlier | pandemic | 1 |
earlier | response | 1 |
earlier | responses | 1 |
earlier | symptom | 1 |
earlier | viruses | 1 |
earliest | day | 1 |
earliest | disease | 1 |
earliest | infections | 1 |
earliest | results | 1 |
earliest | sars | 1 |
earliest | study | 1 |
earliest | symptom | 1 |
covid-19 | caring | 1 |
clinical | virus | 1 |
clinical | times | 1 |
clinical | risks | 1 |
- | cared | 1 |
- | cased | 1 |
- | leveling | 1 |
- | modelled | 1 |
- | risked | 1 |
- | risking | 1 |
acute | cares | 1 |
acute | cell | 1 |
acute | data | 1 |
acute | models | 1 |
acute | risk | 1 |
acute | risks | 1 |
available | cell | 1 |
available | day | 1 |
available | days | 1 |
available | level | 1 |
available | model | 1 |
available | responses | 1 |
available | risk | 1 |
available | symptom | 1 |
available | times | 1 |
clinical | cell | 1 |
clinical | coronavirus | 1 |
clinical | pandemic | 1 |
clinical | result | 1 |
early | cell | 1 |
early | model | 1 |
low | infections | 1 |
large | sars | 1 |
immune | sars | 1 |
important | care | 1 |
important | cases | 1 |
important | covid-19 | 1 |
important | model | 1 |
important | virus | 1 |
important | viruses | 1 |
large | cases | 1 |
large | disease | 1 |
large | pandemic | 1 |
large | pandemics | 1 |
large | responses | 1 |
large | viruses | 1 |
first | modelled | 1 |
larger | analyses | 1 |
larger | analysis | 1 |
larger | infection | 1 |
larger | levels | 1 |
larger | model | 1 |
larger | sars | 1 |
largest | disease | 1 |
largest | model | 1 |
largest | pandemics | 1 |
largest | time | 1 |
low | cells | 1 |
low | et | 1 |
immune | model | 1 |
immune | level | 1 |
humans | infection | 1 |
humans | health | 1 |
first | times | 1 |
first | treatments | 1 |
high | cells | 1 |
high | china | 1 |
high | et | 1 |
high | model | 1 |
high | responses | 1 |
high | resulted | 1 |
high | results | 1 |
high | risked | 1 |
high | study | 1 |
high | symptoms | 1 |
higher | cell | 1 |
higher | coronavirus | 1 |
higher | model | 1 |
highest | coronavirus | 1 |
highest | modeled | 1 |
human | levels | 1 |
human | resulted | 1 |
human | results | 1 |
human | risk | 1 |
human | studied | 1 |
human | treatment | 1 |
humans | case | 1 |
humans | cells | 1 |
viral | time | 1 |